Andrew J. Epstein, PhD
Articles
July 17th 2019
Impact of a Co-pay Accumulator Adjustment Program on Specialty Drug Adherence
Commercial health plan initiation of a co-pay accumulator adjustment program for specialty medications treating autoimmune diseases was associated with significant reductions in medication adherence and persistence.
January 23rd 2014
The Effects of Federal Parity on Substance Use Disorder Treatment
Susan H. Busch, PhD Andrew J. Epstein, PhD Michael O. Harhay, MPH David A. Fiellin, MD Hyong Un, MD Deane Leader Jr, DBA, MBA Colleen L. Barry, PhD, MPP
Federal parity led to an increase in spending on substance use disorder treatment.
Latest Updated Articles
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: July 24th 2024 | Updated: July 27th 2024
Long-Term Follow-Up from CheckMate 9LA at ASCO 2024
Published: July 24th 2024 | Updated: July 27th 2024
Insights from the TROPION-Lung05 Trial at ASCO 2024
Published: July 24th 2024 | Updated: July 27th 2024
Examining Trends, Future Directions in AI and Health Care
Published: July 15th 2024 | Updated: July 27th 2024
No Sex Differences Identified in Aspirin Dosing for Secondary Prevention of ASCVD
Published: July 24th 2024 | Updated: July 27th 2024
Future Directions in the Management of Multiple Myeloma
